Date(s) - Saturday, October 19, 2019
10:30 am - 1:30 pm
Whitpain Township Building
Categories No Categories
We are very excited to have an executive from Fulcrum Therapeutics to address us at this chapter meeting. As you know, they have announced the initiation of ReDUX4, a Phase 2b Clinical Trial of Losmapimod for FSHD. We have been waiting for a treatment of this nature for a long time and it will begin soon. Fulcrum has started the recruitment process and it will fill up quickly. The sooner recruitment is complete, the faster they will be able to begin the formal trial. Getting details from Michelle Mellion, Medical Director for Fulcrum Therapeutics, will help everyone to understand the nature of the treatment and how they plan to proceed.
There are several areas accommodating handicap parking for this location. You should drive in through the main entrance – the building entrance for this session will be on the left as you drive in. It is a one-story building and is easy to navigate. Note that the entrance is also shared by the police department.
“We hope to see you there!” – Bill Maclean, Greater Philadelphia Chapter Director
PLEASE RSVP below: